Medcomtech Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Medcomtech.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 25.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Returns Are Gaining Momentum At Medcomtech (BME:MED)
Oct 18
Many Still Looking Away From Medcomtech, S.A. (BME:MED)
Aug 26Returns At Medcomtech (BME:MED) Are On The Way Up
Mar 21Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital
Dec 06Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist
Aug 16Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital
Apr 09Here's Why Medcomtech (BME:MED) Can Afford Some Debt
May 17Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Nov 30
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medcomtech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 27 | -1 | -4 | -2 | N/A |
| 3/31/2023 | 26 | -2 | -3 | -2 | N/A |
| 12/31/2022 | 25 | -2 | -3 | -2 | N/A |
| 9/30/2022 | 24 | -1 | -3 | -2 | N/A |
| 6/30/2022 | 24 | -1 | -4 | -2 | N/A |
| 3/31/2022 | 23 | -1 | -3 | -1 | N/A |
| 12/31/2021 | 23 | -1 | -2 | 0 | N/A |
| 9/30/2021 | 22 | -1 | -2 | 0 | N/A |
| 6/30/2021 | 22 | -1 | -2 | 0 | N/A |
| 3/31/2021 | 20 | -2 | -2 | 0 | N/A |
| 12/31/2020 | 19 | -2 | -2 | -1 | N/A |
| 9/30/2020 | 19 | -4 | -2 | -1 | N/A |
| 6/30/2020 | 19 | -6 | -1 | -1 | N/A |
| 3/31/2020 | 21 | -1 | -2 | -2 | N/A |
| 12/31/2019 | 22 | 4 | -3 | -2 | N/A |
| 9/30/2019 | 22 | 4 | -3 | -2 | N/A |
| 6/30/2019 | 22 | 4 | -2 | -1 | N/A |
| 3/31/2019 | 23 | -2 | 0 | 1 | N/A |
| 12/31/2018 | 24 | -8 | 2 | 3 | N/A |
| 9/30/2018 | 26 | -8 | 3 | 4 | N/A |
| 6/30/2018 | 28 | -7 | 5 | 5 | N/A |
| 3/31/2018 | 28 | -5 | 3 | 3 | N/A |
| 12/31/2017 | 29 | -3 | 1 | 2 | N/A |
| 12/31/2016 | 28 | -3 | N/A | 1 | N/A |
| 12/31/2015 | 25 | -1 | N/A | -2 | N/A |
| 6/30/2015 | 22 | 0 | N/A | 2 | N/A |
| 3/31/2015 | 21 | 1 | N/A | 1 | N/A |
| 12/31/2014 | 20 | 1 | N/A | 1 | N/A |
| 9/30/2014 | 20 | 1 | N/A | N/A | N/A |
| 6/30/2014 | 19 | 1 | N/A | 0 | N/A |
| 3/31/2014 | 19 | 1 | N/A | 1 | N/A |
| 12/31/2013 | 18 | 1 | N/A | 3 | N/A |
| 9/30/2013 | 18 | 1 | N/A | N/A | N/A |
| 6/30/2013 | 17 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MED's forecast earnings growth is above the savings rate (1.4%).
Earnings vs Market: Insufficient data to determine if MED's earnings are forecast to grow faster than the Spanish market
High Growth Earnings: Insufficient data to determine if MED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MED's revenue is forecast to grow faster than the Spanish market.
High Growth Revenue: Insufficient data to determine if MED's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MED's Return on Equity is forecast to be high in 3 years time